The Bottom Line PT-141 is the only FDA-approved, non-hormonal peptide therapy for female sexual desire disorder
Tirzepatide and semaglutide both fall into the GLP-1 medication category, but they are different
Myriocin is a highly specific inhibitor of serine palmitoyltransferase (SPT), which is the first and rate-limiting enzyme in the de novo pathway of ceramide synthesis
Based on the annualized event rates in the semaglutide and placebo groups, the SOUL trial was calculated to accumulate 1225 events at the end of 3.78 years, resulting in premature termination (Fig
Inform the TSA agent immediately that you're carrying injectable medicationthis transparency prevents alarms and expedites screening
PRICING For Medical Weight Loss, we begin with a Wellness Consult and Lab Draw at our office in Kansas City to help you start looking and feeling your best